Literature DB >> 22809979

Meningitis and encephalitis.

Karen L Roos, John E Greenlee.   

Abstract

PURPOSE OF REVIEW: : Neurologists have a vital role in the recognition of meningitis and encephalitis, the accurate evaluation and interpretation of CSF studies, and the management and prevention of the neurologic complications of CNS infectious diseases. RECENT
FINDINGS: ;: Although the tetravalent meningococcal glycoconjugate vaccine has decreased the incidence of meningococcal meningitis, the vaccine does not contain serogroup B, which is responsible for one-third of cases of meningococcal disease. Thus, meningitis due to Neisseria meningitidis is still a concern in a vaccinated individual. Empiric therapy for meningitis associated with sinusitis, otitis, or mastoiditis should include antibiotic therapy for anaerobes. An organism that classically causes a subacute or chronic meningitis, such as Mycobacterium tuberculosis, may on occasion present with an acute onset of symptoms.
SUMMARY: ;: Unlike most other diseases, the management of patients with suspected meningitis or encephalitis begins with empiric therapy. The etiologic organism cannot always be identified. The goal is to identify those that are treatable, provide supportive care for those that are not, and, when possible, prevent the neurologic complications of these infections.

Entities:  

Year:  2011        PMID: 22809979     DOI: 10.1212/01.CON.0000407057.02414.a9

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  2 in total

1.  The diagnostic conundrum and treatment dilemma of a patient with a rapidly progressive encephalopathy.

Authors:  Christopher W Beatty; Claire J Creutzfeldt; Arielle P Davis; Zachary Hoffer; Sandeep P Khot
Journal:  Neurohospitalist       Date:  2014-01

2.  Improving the diagnosis of meningitis due to enterovirus and herpes simplex virus I and II in a tertiary care hospital.

Authors:  Eduardo Casaroto; Alexandre R Marra; Fernando Morgadinho S Coelho; Joao Renato Rebello Pinho; Roberta Sitnik; Fernando Colombari; Elivane Silva Victor; Nair Hideko Muto; Carlos Senne; Oscar Fernando Pavão dos Santos; Michael B Edmond
Journal:  BMC Infect Dis       Date:  2013-10-21       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.